Dolby Laboratories Inc.

NYSE: DLB · Real-Time Price · USD
72.64
0.11 (0.15%)
At close: Aug 15, 2025, 3:03 PM

Dolby Laboratories Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 28, 2025 Dec 27, 2024 Sep 27, 2024 Jun 28, 2024 Mar 29, 2024 Dec 29, 2023 Sep 29, 2023 Jun 30, 2023 Mar 31, 2023 Dec 30, 2022 Sep 30, 2022 Jul 1, 2022 Apr 1, 2022 Dec 31, 2021 Sep 24, 2021 Jun 25, 2021 Mar 26, 2021 Dec 25, 2020
Revenue
369.56M 357M 304.81M 288.82M 364.52M 315.57M 290.56M 298.37M 375.89M 334.92M 278.2M 289.58M 334.37M 351.63M 285.02M 286.8M 319.56M 389.87M
Cost of Revenue
35.84M 40.77M 34M 35.66M 38.78M 32.06M 35.55M 41.52M 41.05M 34.45M 37.18M 35.96M 35.52M 32.71M 30.7M 31.64M 32.38M 35.3M
Gross Profit
333.72M 316.23M 270.81M 253.16M 325.75M 283.51M 255.01M 256.86M 334.84M 300.47M 241.03M 253.63M 298.86M 318.92M 254.33M 255.16M 287.18M 354.57M
Operating Income
107.76M 79.88M 45.06M 36.78M 108.97M 66.22M -3.49M 15.94M 84.7M 94.09M 13.12M 45.57M 43.35M 90.58M 40.37M 56.09M 83.19M 164.75M
Interest Income
n/a n/a 6.85M n/a 8.6M n/a n/a 7.32M 6.81M 4.88M 3.34M 1.42M 1.1M 716K 816K 741K 962K 974K
Pretax Income
120.25M 86.05M 59.73M 50.16M 121.75M 80.83M 9.03M 23.76M 117.28M 99.98M 30.97M 49.41M 43.45M 91.44M 43.06M 59.13M 85.37M 166.96M
Net Income
91.79M 67.82M 58.57M 38.44M 97.83M 66.98M 9.19M 16.4M 95.7M 79.38M 27.76M 39.6M 36.72M 80.01M 44.19M 54.62M 76.22M 135.2M
Selling & General & Admin
160.04M 164.49M 154.37M 146.79M 156.78M 144.17M 157.48M 155.55M 157.63M 142.18M 147.27M 144.23M 182.92M 159.61M 152.66M 136.83M 137.44M 129.9M
Research & Development
61.71M 66.64M 68.64M 65.5M 62.49M 67.03M 70.43M 68.7M 67.95M 64.45M 62.07M 62.86M 67.42M 68.82M 61.97M 62.09M 65.81M 63.77M
Other Expenses
4.21M 5.22M 2.74M 4.08M -2.5M 6.09M n/a 620K 1.25M 1.1M 667K n/a -910K 229K 2M n/a 1.39M 1.33M
Operating Expenses
225.96M 236.34M 225.75M 216.37M 216.78M 217.29M 227.91M 224.24M 225.59M 206.63M 209.34M 207.09M 250.34M 228.44M 214.63M 198.92M 203.25M 193.67M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a 114K n/a 81K 139K 84K 87K 84K 119K 108K 167K 85K
Selling & Marketing Expenses
89.63M 94.4M n/a 77.52M 90.04M 79M 90.87M 85.59M 95.69M 82.2M 90.2M 87.11M 84.23M 97.17M 98.47M 80.71M 78.05M 75.44M
Cost & Expenses
261.8M 271.9M 259.74M 252.03M 255.56M 249.35M 263.46M 265.76M 266.63M 241.08M 246.52M 243.04M 285.86M 261.15M 245.32M 230.57M 235.63M 228.97M
Income Tax Expense
28.02M 17.98M 868K 10.51M 23.53M 13.25M -875K 7.35M 21.4M 20.53M 3.21M 9.8M 6.93M 11.43M -1.17M 4.57M 9.02M 24.27M
Shares Outstanding (Basic)
96.33M 95.61M 95.39M 95.69M 95.72M 95.38M 95.7M 95.66M 95.82M 95.91M 97.08M 100.21M 101.34M 101.23M 101.23M 101.35M 101.46M 100.72M
Shares Outstanding (Diluted)
97.47M 97.15M 96.59M 96.96M 96.86M 97.44M 97.68M 97.46M 97.3M 97.05M 98.46M 101.47M 102.71M 103.8M 104.37M 104.63M 104.58M 103.88M
EPS (Basic)
0.95 0.71 1.23 0.40 1.02 0.70 0.10 0.17 1.00 0.83 0.29 0.40 0.36 0.79 0.44 0.54 0.75 1.34
EPS (Diluted)
0.94 0.70 1.21 0.40 1.01 0.69 0.09 0.17 0.98 0.82 0.28 0.39 0.36 0.77 0.42 0.52 0.73 1.30
EBITDA
136.4M 110.29M 59.73M 62.07M 127.25M 93.27M 81.95M 64.85M 109.29M 122.18M 35.69M 77.73M 75.06M 118.85M 42.51M 82.67M 111.51M 185.37M
EBIT
111.97M 86.05M 59.73M 40.86M 106.47M 72.31M n/a n/a 84.7M 94.09M 13.12M 45.57M 43.35M 90.58M n/a n/a n/a 164.75M
Depreciation & Amortization
24.43M 25.2M 14.67M 21.21M 20.78M 20.96M 24.26M 24.3M 24.59M 28.09M 22.57M 32.16M 31.71M 27.42M 42.06M 23.3M 25.23M 22.17M